Biphasic Euchromatin-to-Heterochromatin Transition on the KSHV Genome Following Infection

English version České info

The establishment of latency is an essential step for the life-long persistent infection and pathogenesis of Kaposi's sarcoma-associated herpesvirus (KSHV). While the KSHV genome is chromatin-free in the virions, the viral DNA in latently infected cells has a chromatin structure with activating and repressive histone modifications that promote latent gene expression but suppress lytic gene expression. Here, we report a comprehensive epigenetic study of the recruitment of chromatin regulatory factors onto the KSHV genome during the pre-latency phase of KSHV infection. This demonstrates that the KSHV genome undergoes a biphasic chromatinization following de novo infection. Initially, a transcriptionally active chromatin (euchromatin), characterized by high levels of the H3K4me3 and acetylated H3K27 (H3K27ac) activating histone marks, was deposited on the viral episome and accompanied by the transient induction of a limited number of lytic genes. Interestingly, temporary expression of the RTA protein facilitated the increase of H3K4me3 and H3K27ac occupancy on the KSHV episome during de novo infection. Between 24–72 hours post-infection, as the levels of these activating histone marks declined on the KSHV genome, the levels of the repressive H3K27me3 and H2AK119ub histone marks increased concomitantly with the decline of lytic gene expression. Importantly, this transition to heterochromatin was dependent on both Polycomb Repressive Complex 1 and 2. In contrast, upon infection of human gingiva-derived epithelial cells, the KSHV genome underwent a transcription-active euchromatinization, resulting in efficient lytic gene expression. Our data demonstrate that the KSHV genome undergoes a temporally-ordered biphasic euchromatin-to-heterochromatin transition in endothelial cells, leading to latent infection, whereas KSHV preferentially adopts a transcriptionally active euchromatin in oral epithelial cells, resulting in lytic gene expression. Our results suggest that the differential epigenetic modification of the KSHV genome in distinct cell types is a potential determining factor for latent infection versus lytic replication of KSHV.

Vyšlo v časopise: Biphasic Euchromatin-to-Heterochromatin Transition on the KSHV Genome Following Infection. PLoS Pathog 9(12): e32767. doi:10.1371/journal.ppat.1003813
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1003813

Souhrn

Zdroje

1. CesarmanE, MoorePS, RaoPH, InghiramiG, KnowlesDM, et al. (1995) In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 86: 2708–2714.

2. ChangY, CesarmanE, PessinMS, LeeF, CulpepperJ, et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865–1869.

3. GreeneW, KuhneK, YeF, ChenJ, ZhouF, et al. (2007) Molecular biology of KSHV in relation to AIDS-associated oncogenesis. Cancer treatment and research 133: 69–127.

4. YeF, ZhouF, BedollaRG, JonesT, LeiX, et al. (2011) Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latency. PLoS Pathog 7: e1002054.

5. ChangJ, RenneR, DittmerD, GanemD (2000) Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication. Virology 266: 17–25.

6. BechtelJT, LiangY, HviddingJ, GanemD (2003) Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells. J Virol 77: 6474–6481.

7. BallestasME, KayeKM (2011) The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency. Future microbiology 6: 1399–1413.

8. LuF, ZhouJ, WiedmerA, MaddenK, YuanY, et al. (2003) Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency. J Virol 77: 11425–11435.

9. RenneR, LagunoffM, ZhongW, GanemD (1996) The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J Virol 70: 8151–8154.

10. TothZ, BruloisK, JungJU (2013) The Chromatin Landscape of Kaposi's Sarcoma-Associated Herpesvirus. Viruses 5: 1346–1373.

11. TothZ, MaglinteDT, LeeSH, LeeHR, WongLY, et al. (2010) Epigenetic analysis of KSHV latent and lytic genomes. PLoS Pathog 6: e1001013.

12. GuntherT, GrundhoffA (2010) The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathog 6: e1000935.

13. SimonJA, KingstonRE (2009) Mechanisms of polycomb gene silencing: knowns and unknowns. Nature reviews Molecular cell biology 10: 697–708.

14. FrancisNJ, KingstonRE, WoodcockCL (2004) Chromatin compaction by a polycomb group protein complex. Science 306: 1574–1577.

15. TavaresL, DimitrovaE, OxleyD, WebsterJ, PootR, et al. (2012) RYBP-PRC1 complexes mediate H2A ubiquitylation at polycomb target sites independently of PRC2 and H3K27me3. Cell 148: 664–678.

16. GaoZ, ZhangJ, BonasioR, StrinoF, SawaiA, et al. (2012) PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes. Molecular cell 45: 344–356.

17. KrishnanHH, NaranattPP, SmithMS, ZengL, BloomerC, et al. (2004) Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J Virol 78: 3601–3620.

18. MyoungJ, GanemD (2011) Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction. J Virol Methods 174: 12–21.

19. BruloisKF, ChangH, LeeAS, EnsserA, WongLY, et al. (2012) Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone. J Virol 86: 9708–9720.

20. HiltonIB, SimonJM, LiebJD, DavisIJ, DamaniaB, et al. (2013) The Open Chromatin Landscape of Kaposi's Sarcoma-Associated Herpesvirus. J Virol 87: 11831–11842.

21. TothZ, BruloisKF, WongLY, LeeHR, ChungB, et al. (2012) Negative elongation factor-mediated suppression of RNA polymerase II elongation of Kaposi's sarcoma-associated herpesvirus lytic gene expression. J Virol 86: 9696–9707.

22. GwackY, BaekHJ, NakamuraH, LeeSH, MeisterernstM, et al. (2003) Principal role of TRAP/mediator and SWI/SNF complexes in Kaposi's sarcoma-associated herpesvirus RTA-mediated lytic reactivation. Mol Cell Biol 23: 2055–2067.

23. NakamuraH, LuM, GwackY, SouvlisJ, ZeichnerSL, et al. (2003) Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator. J Virol 77: 4205–4220.

24. SharadK, VermaXT, LaFranceLV, DuquenneC, SuarezDP, et al. (2012) Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2. ACS Med Chem Lett 3: 1091–1096.

25. VieiraJ, O'HearnPM (2004) Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. Virology 325: 225–240.

26. DuusKM, LentchitskyV, WagenaarT, GroseC, Webster-CyriaqueJ (2004) Wild-type Kaposi's sarcoma-associated herpesvirus isolated from the oropharynx of immune-competent individuals has tropism for cultured oral epithelial cells. J Virol 78: 4074–4084.

27. KangH, WiedmerA, YuanY, RobertsonE, LiebermanPM (2011) Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation. PLoS Pathog 7: e1002140.

28. PerssonLM, WilsonAC (2010) Wide-scale use of Notch signaling factor CSL/RBP-Jkappa in RTA-mediated activation of Kaposi's sarcoma-associated herpesvirus lytic genes. J Virol 84: 1334–1347.

29. PasiniD, MalatestaM, JungHR, WalfridssonJ, WillerA, et al. (2010) Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes. Nucleic Acids Res 38: 4958–4969.

30. EstarasC, FueyoR, AkizuN, BeltranS, Martinez-BalbasMA (2013) RNA polymerase II progression through H3K27me3-enriched gene bodies requires JMJD3 histone demethylase. Molecular biology of the cell 24: 351–360.

31. LeeJH, SkalnikDG (2008) Wdr82 is a C-terminal domain-binding protein that recruits the Setd1A Histone H3-Lys4 methyltransferase complex to transcription start sites of transcribed human genes. Mol Cell Biol 28: 609–618.

32. MilneTA, DouY, MartinME, BrockHW, RoederRG, et al. (2005) MLL associates specifically with a subset of transcriptionally active target genes. Proc Natl Acad Sci U S A 102: 14765–14770.

33. HughesCM, Rozenblatt-RosenO, MilneTA, CopelandTD, LevineSS, et al. (2004) Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Molecular cell 13: 587–597.

34. SunR, LinSF, GradovilleL, YuanY, ZhuF, et al. (1998) A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 95: 10866–10871.

35. ChangPC, FitzgeraldLD, Van GeelenA, IzumiyaY, EllisonTJ, et al. (2009) Kruppel-associated box domain-associated protein-1 as a latency regulator for Kaposi's sarcoma-associated herpesvirus and its modulation by the viral protein kinase. Cancer Res 69: 5681–5689.

36. BudtM, HristozovaT, HilleG, BergerK, BruneW (2011) Construction of a lytically replicating Kaposi's sarcoma-associated herpesvirus. J Virol 85: 10415–10420.

37. KnipeDM, CliffeA (2008) Chromatin control of herpes simplex virus lytic and latent infection. Nature reviews Microbiology 6: 211–221.

38. KwiatkowskiDL, ThompsonHW, BloomDC (2009) The polycomb group protein Bmi1 binds to the herpes simplex virus 1 latent genome and maintains repressive histone marks during latency. J Virol 83: 8173–8181.

39. CliffeAR, GarberDA, KnipeDM (2009) Transcription of the herpes simplex virus latency-associated transcript promotes the formation of facultative heterochromatin on lytic promoters. J Virol 83: 8182–8190.

40. AbrahamCG, KuleszaCA (2013) Polycomb Repressive Complex 2 Silences Human Cytomegalovirus Transcription in Quiescent Infection Models. J Virol [Epub ahead of print].

41. WoellmerA, Arteaga-SalasJM, HammerschmidtW (2012) BZLF1 governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression. PLoS Pathog 8: e1002902.

42. MurataT, KondoY, SugimotoA, KawashimaD, SaitoS, et al. (2012) Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells. J Virol 86: 4752–4761.

43. KutluaySB, TriezenbergSJ (2009) Regulation of histone deposition on the herpes simplex virus type 1 genome during lytic infection. J Virol 83: 5835–5845.

44. NitzscheA, PaulusC, NevelsM (2008) Temporal dynamics of cytomegalovirus chromatin assembly in productively infected human cells. J Virol 82: 11167–11180.

45. KentJR, ZengPY, AtanasiuD, GardnerJ, FraserNW, et al. (2004) During lytic infection herpes simplex virus type 1 is associated with histones bearing modifications that correlate with active transcription. J Virol 78: 10178–10186.

46. GiresiPG, KimJ, McDaniellRM, IyerVR, LiebJD (2007) FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) isolates active regulatory elements from human chromatin. Genome research 17: 877–885.